2m 2m 2m 2m 2m 2m 2m
VYNE THERAP (VYNE)
NASDAQ
$0.65-$0.004 (-0.62%)
Price as of Jun 23, 2026 7:00 PM EDT- $21.7MMarket Cap
- -28.89%1-Year Change
- BiotechnologyIndustry
VYNE THERAP (VYNE)
$0.65-$0.004 (-0.62%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 13.07% | 2.2M | -152,449 (-7.00%) | Dec 31, 2021 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 12.00% | 2.0M | +1.0M (+50.00%) | Mar 31, 2026 |
LYNX1 CAPITAL MANAGEMENT LP | 9.77% | 1.6M | +1.6M (+100.00%) | Mar 31, 2026 |
SHAY CAPITAL LLC | 9.66% | 1.6M | -14,107 (-0.88%) | Mar 31, 2026 |
ANSON FUNDS MANAGEMENT LP | 7.46% | 1.2M | -31,280 (-2.52%) | Mar 31, 2026 |
ADAR1 CAPITAL MANAGEMENT, LLC | 6.38% | 1.1M | +810,108 (+76.15%) | Mar 31, 2026 |
N/A | 5.67% | 945,000 | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 40.50% | 6.7M | 0 (0.00%) | Mar 31, 2026 |
FRANKLIN STRATEGIC SERIES | 17.30% | 2.9M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY CONCORD STREET TRUST | 6.71% | 1.1M | 0 (0.00%) | Feb 28, 2026 |
FIDELITY SALEM STREET TRUST | 5.83% | 970,951 | 0 (0.00%) | Mar 31, 2026 |
Listed Funds Trust | 2.94% | 490,430 | 0 (0.00%) | Apr 30, 2026 |
EQ ADVISORS TRUST | 2.73% | 454,622 | 0 (0.00%) | Mar 31, 2026 |
TEKLA HEALTHCARE INVESTORS | 2.27% | 379,103 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Mutual Funds108.9M (55.77%)
- Institutions76.5M (39.17%)
- Insiders9.9M (5.06%)
- Other0 (0.00%)
Insider Transactions
- 5.06% (9.9M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Mar 31, 2026 | $2,394.18 | 4,007 | $0.60 | 121,898 |
Domzalski David PRESIDENT AND CEO | In Kind | Mar 31, 2026 | $8,503.62 | 14,232 | $0.60 | 401,976 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Mar 31, 2026 | $2,394.18 | 4,007 | $0.60 | 99,788 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Mar 31, 2026 | $1,718.41 | 2,876 | $0.60 | 112,363 |
Domzalski David PRESIDENT AND CEO | In Kind | Dec 31, 2025 | $7,357.99 | 12,684 | $0.58 | 416,208 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Dec 31, 2025 | $4,558.43 | 7,858 | $0.58 | 103,795 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Dec 31, 2025 | $2,076.18 | 3,579 | $0.58 | 125,905 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Dec 31, 2025 | $1,420.08 | 2,448 | $0.58 | 115,239 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Sep 30, 2025 | $821.75 | 2,453 | $0.34 | 117,687 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Sep 30, 2025 | $1,199.63 | 3,581 | $0.34 | 129,484 |
Domzalski David PRESIDENT AND CEO | In Kind | Sep 30, 2025 | $4,246.46 | 12,676 | $0.34 | 428,892 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Sep 30, 2025 | $1,145.70 | 3,420 | $0.34 | 111,653 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Jun 30, 2025 | $4,047.45 | 2,453 | $1.65 | 120,140 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Jun 30, 2025 | $5,908.65 | 3,581 | $1.65 | 133,065 |
Domzalski David PRESIDENT AND CEO | In Kind | Jun 30, 2025 | $20,915.40 | 12,676 | $1.65 | 441,568 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Jun 30, 2025 | $5,643.00 | 3,420 | $1.65 | 115,073 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | Award | Jun 02, 2025 | $927.45 | 1,145 | $0.81 | 136,646 |
Domzalski David PRESIDENT AND CEO | Award | Jun 02, 2025 | $7,031.61 | 8,681 | $0.81 | 454,244 |
Domzalski David PRESIDENT AND CEO | In Kind | Mar 31, 2025 | $48,186.84 | 30,498 | $1.58 | 445,563 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Mar 31, 2025 | $13,270.42 | 8,399 | $1.58 | 118,493 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Mar 31, 2025 | $13,948.24 | 8,828 | $1.58 | 135,501 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Mar 31, 2025 | $9,549.52 | 6,044 | $1.58 | 122,593 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | Award | Jan 21, 2025 | $0.00 | 230,000 | $0.00 | 230,000 |
Domzalski David PRESIDENT AND CEO | Award | Jan 21, 2025 | $0.00 | 730,000 | $0.00 | 730,000 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | Award | Jan 21, 2025 | $0.00 | 230,000 | $0.00 | 230,000 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | Award | Jan 21, 2025 | $0.00 | 230,000 | $0.00 | 230,000 |
LEPORE PATRICK G | Buy | Jan 15, 2025 | $43,800.00 | 15,000 | $2.92 | 51,472 |
Zeronda Tyler CHIEF FINANCIAL OFFICER | In Kind | Dec 31, 2024 | $15,661.25 | 4,675 | $3.35 | 126,892 |
Stuart Iain CHIEF SCIENTIFIC OFFICER | In Kind | Dec 31, 2024 | $16,270.95 | 4,857 | $3.35 | 128,637 |
Harsch Mutya CHIEF LEGAL OFFICER AND GC | In Kind | Dec 31, 2024 | $15,734.95 | 4,697 | $3.35 | 144,329 |